biote
BTMD

biote (BTMD) analyst forecast and price target

Analyst forecast

Buy

Consensus of 4 analyst ratings

Buy
3
Hold
1
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
B. Riley SecuritiesMaintainedNeutral$1.50 from $2.00Aug 10, 2026
TD CowenMaintainedBuy$2.00 from $2.50Aug 7, 2026
Truist SecuritiesMaintainedBuy$4.00 from $5.00Apr 16, 2026
TD CowenMaintainedBuy$2.50 from $3.00Mar 12, 2026
B. Riley SecuritiesMaintainedNeutral$2.00 from $3.00Mar 12, 2026
B. Riley SecuritiesDowngradedBuy → Neutral$4.00 from $8.00Aug 7, 2025
Craig-HallumMaintainedBuy$8.00 from $12.00Mar 13, 2025
Craig-HallumInitiated CoverageBuy$12.00Dec 16, 2024
Roth MKMMaintainedBuy$9.00 from $8.00Mar 13, 2024
B. Riley SecuritiesInitiated CoverageBuy$9.00Feb 20, 2024
JefferiesInitiated CoverageBuy$6.55Feb 1, 2024
Roth MKMMaintainedBuy$7.00 from $8.00Jan 18, 2024
Truist SecuritiesMaintainedBuy$9.00 from $10.00Jan 18, 2024
TD CowenMaintainedOutperform$7.00 from $12.00Aug 15, 2023
Roth MKMMaintainedBuy$12.00Aug 14, 2023
Roth MKMMaintainedBuy$11.00 from $10.00Mar 30, 2023

Frequently asked questions

  • Is BTMD a buy, sell, or hold?

    Analysts covering biote currently average a Buy rating: 3 buy, 1 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on BTMD?

    On Aug 10, 2026, B. Riley Securities maintained biote at Neutral with a price target of $1.50.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.